• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用miR-31修饰的骨髓间充质干细胞修复犬眼眶内侧骨缺损

Repair of canine medial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells.

作者信息

Deng Yuan, Zhou Huifang, Gu Ping, Fan Xianqun

机构信息

Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Invest Ophthalmol Vis Sci. 2014 Aug 28;55(9):6016-23. doi: 10.1167/iovs.14-14977.

DOI:10.1167/iovs.14-14977
PMID:25168901
Abstract

PURPOSE

To investigate the role of miR-31 genetically modified bone marrow mesenchymal stem cells (BMSCs) composited with porous β-tricalcium phosphate (β-TCP) scaffolds in repairing canine medial orbital wall defects.

METHODS

A circular bone defect (10 mm in diameter) was created on the canine medial orbital wall. After canine BMSCs were isolated and transfected with lentiviral vectors encoding miR-31, anti-miR-31 (anti-miR), and negative control (miR-Neg) in vitro, they were seeded onto porous β-TCP scaffolds and implanted to repair the orbital defects. Spiral computed tomography (CT) scans were conducted at 4 and 16 weeks after surgery. Micro-CT and histological analysis were performed at 16 weeks after surgery. The results were analyzed to evaluate the extent of bone repair.

RESULTS

Examination with CT revealed good recovery in the anti-miR group at 16 weeks after surgery. In addition, the micro-CT analysis showed that the bone mineral density and new bone volume increased in the anti-miR group and decreased in the miR-31 group compared with that in the miR-Neg group. Histologic analysis confirmed that the formation of new bone and extent of β-TCP degradation were enhanced in the anti-miR and attenuated in the miR-31 group. In situ hybridization and immunohistochemical analysis further confirmed the micro-CT findings.

CONCLUSIONS

The use of BMSCs with suppression of miR-31 expression combined with β-TCP scaffolds can efficiently repair medial orbital wall defects in dogs.

摘要

目的

探讨基因修饰的微小RNA-31(miR-31)骨髓间充质干细胞(BMSCs)与多孔β-磷酸三钙(β-TCP)支架复合在修复犬眼眶内侧壁缺损中的作用。

方法

在犬眼眶内侧壁制造一个直径10毫米的圆形骨缺损。犬BMSCs在体外分离后,分别用编码miR-31、抗miR-31(抗miR)和阴性对照(miR-Neg)的慢病毒载体转染,然后接种到多孔β-TCP支架上,植入以修复眼眶缺损。术后4周和16周进行螺旋计算机断层扫描(CT)。术后16周进行显微CT和组织学分析。分析结果以评估骨修复程度。

结果

CT检查显示抗miR组在术后16周恢复良好。此外,显微CT分析表明,与miR-Neg组相比,抗miR组骨矿物质密度和新骨体积增加,miR-31组降低。组织学分析证实,抗miR组新骨形成和β-TCP降解程度增强,miR-31组减弱。原位杂交和免疫组化分析进一步证实了显微CT的结果。

结论

使用抑制miR-31表达的BMSCs与β-TCP支架联合可有效修复犬眼眶内侧壁缺损。

相似文献

1
Repair of canine medial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells.用miR-31修饰的骨髓间充质干细胞修复犬眼眶内侧骨缺损
Invest Ophthalmol Vis Sci. 2014 Aug 28;55(9):6016-23. doi: 10.1167/iovs.14-14977.
2
Orbital wall repair in canines with beta-tricalcium phosphate and induced bone marrow stromal cells.使用β-磷酸三钙和诱导骨髓基质细胞对犬进行眶壁修复。
J Biomed Mater Res B Appl Biomater. 2013 Nov;101(8):1340-9. doi: 10.1002/jbm.b.32951. Epub 2013 May 17.
3
In vitro osteogenic induction of bone marrow stromal cells with encapsulated gene-modified bone marrow stromal cells and in vivo implantation for orbital bone repair.用封装的基因修饰骨髓基质细胞对骨髓基质细胞进行体外成骨诱导及体内植入用于眼眶骨修复。
Tissue Eng Part A. 2014 Jul;20(13-14):2019-29. doi: 10.1089/ten.TEA.2013.0604. Epub 2014 Apr 11.
4
In vivo efficacy of bone marrow stromal cells coated with beta-tricalcium phosphate for the reconstruction of orbital defects in canines.经β-磷酸三钙涂层骨髓基质细胞在犬眼眶缺损重建中的体内疗效。
Invest Ophthalmol Vis Sci. 2011 Mar 25;52(3):1735-41. doi: 10.1167/iovs.10-5988.
5
Repair of orbital wall defects using biocoral scaffolds combined with bone marrow stem cells enhanced by human bone morphogenetic protein-2 in a canine model.采用珊瑚骨支架联合人骨形态发生蛋白-2 复合骨髓间充质干细胞修复犬眶壁缺损的实验研究。
Int J Mol Med. 2010 Oct;26(4):517-25. doi: 10.3892/ijmm_00000494.
6
Repair of orbital bone defects in canines using grafts of enriched autologous bone marrow stromal cells.利用富含自体骨髓基质细胞的移植物修复犬类眼眶骨缺损。
J Transl Med. 2014 May 11;12:123. doi: 10.1186/1479-5876-12-123.
7
Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds.β-磷酸三钙支架中人骨髓单个核细胞、未分化和成骨分化骨髓间充质干细胞异位骨再生。
Tissue Eng Part C Methods. 2012 Jul;18(7):545-56. doi: 10.1089/ten.TEC.2011.0470. Epub 2012 Feb 22.
8
Introduction of a mixture of β-tricalcium phosphate into a complex of bone marrow mesenchymal stem cells and type I collagen can augment the volume of alveolar bone without impairing cementum regeneration.将β-磷酸三钙混合物引入骨髓间充质干细胞与I型胶原复合物中,可增加牙槽骨体积,且不影响牙骨质再生。
J Periodontol. 2015 Mar;86(3):456-64. doi: 10.1902/jop.2014.140384. Epub 2014 Dec 12.
9
Tissue-engineered bone formation in vivo for artificial laminae of the vertebral arch using β-tricalcium phosphate bioceramics seeded with mesenchymal stem cells.采用骨髓间充质干细胞种植于β-磷酸三钙生物陶瓷构建组织工程骨修复人工脊柱椎弓
Spine (Phila Pa 1976). 2013 Oct 1;38(21):E1300-6. doi: 10.1097/BRS.0b013e3182a3cbb3.
10
The effect of autologous bone marrow stromal cells differentiated on scaffolds for canine tibial bone reconstruction.自体骨髓基质细胞在支架上分化对犬胫骨骨重建的影响。
Biotech Histochem. 2015;90(7):516-28. doi: 10.3109/10520295.2014.983547. Epub 2015 May 21.

引用本文的文献

1
Time to consider fracture nonunion an orphan disease? An update into pathophysiology, epidemiology and therapeutic solutions.是时候将骨折不愈合视为一种罕见病了?骨折不愈合的病理生理学、流行病学及治疗方案的最新进展
Eur J Trauma Emerg Surg. 2025 Jul 21;51(1):255. doi: 10.1007/s00068-025-02918-3.
2
The Use of Functional Biomaterials in Aesthetic and Functional Restoration in Orbital Surgery.功能性生物材料在眼眶手术美学与功能修复中的应用
J Funct Biomater. 2024 Jan 29;15(2):33. doi: 10.3390/jfb15020033.
3
Research Progress of Design Drugs and Composite Biomaterials in Bone Tissue Engineering.
设计药物和复合生物材料在骨组织工程中的研究进展。
Int J Nanomedicine. 2023 Jul 1;18:3595-3622. doi: 10.2147/IJN.S415666. eCollection 2023.
4
Exploring microRNAs in craniofacial regenerative medicine.探索颅面再生医学中的 microRNAs。
Biochem Soc Trans. 2023 Apr 26;51(2):841-854. doi: 10.1042/BST20221448.
5
Bone marrow mesenchymal stem cell's exosomes as key nanoparticles in osteogenesis and bone regeneration: specific capacity based on cell type.骨髓间充质干细胞外泌体作为成骨和骨再生中的关键纳米颗粒:基于细胞类型的特定能力。
Mol Biol Rep. 2022 Dec;49(12):12203-12218. doi: 10.1007/s11033-022-07807-1. Epub 2022 Oct 12.
6
Challenges and strategy in treatment with exosomes for cell-free-based tissue engineering in dentistry.牙科中用于无细胞组织工程的外泌体治疗面临的挑战与策略
Future Sci OA. 2021 Oct 28;7(10):FSO751. doi: 10.2144/fsoa-2021-0050. eCollection 2021 Dec.
7
New Insights Into Monogenic Causes of Osteoporosis.骨质疏松症单基因病因的新见解
Front Endocrinol (Lausanne). 2019 Feb 25;10:70. doi: 10.3389/fendo.2019.00070. eCollection 2019.
8
Comparative study of BMP-2 alone and combined with VEGF carried by hydrogel for maxillary alveolar bone regeneration.水凝胶负载的单独BMP-2与联合VEGF用于上颌牙槽骨再生的比较研究。
Tissue Eng Regen Med. 2016 Apr 5;13(2):171-181. doi: 10.1007/s13770-015-0046-y. eCollection 2016 Apr.
9
Mesenchymal stem cell-derived exosomes have altered microRNA profiles and induce osteogenic differentiation depending on the stage of differentiation.间充质干细胞来源的外泌体具有改变的 microRNA 谱,并根据分化阶段诱导成骨分化。
PLoS One. 2018 Feb 15;13(2):e0193059. doi: 10.1371/journal.pone.0193059. eCollection 2018.
10
MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives.骨科研究中的微小RNA:疾病关联、潜在治疗应用及展望
J Orthop Res. 2018 Jan;36(1):33-51. doi: 10.1002/jor.23822. Epub 2017 Dec 19.